Watershed Therapeutics: Funding, Investors & Team (Sep 2026)
Watershed Therapeutics develops a novel, targeted drug-delivery platform for bladder diseases. The initial aim is to stop recurring urinary tract infections. The therapy can be tailored to help patients with overactive bladder, painful bladder syndrome, and bladder cancer.
Watershed Therapeutics has raised $300k across 1 funding round on record, the most recent an undisclosed round of $300k announced in Apr 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Watershed Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Watershed Therapeutics Funding Rounds
Watershed Therapeutics Founders and Leadership Team
Contact details for the Watershed Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Watershed Therapeutics Funding Compared to Other Biotechnology Startups
Watershed Therapeutics' latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Watershed Therapeutics in Biotechnology and Los Altos
Companies Similar to Watershed Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Watershed Therapeutics Funding FAQs
What does Watershed Therapeutics do?
Watershed Therapeutics develops a novel, targeted drug-delivery platform for bladder diseases. The initial aim is to stop recurring urinary tract infections. The therapy can be tailored to help patients with overactive bladder, painful bladder syndrome, and bladder cancer.
How much funding has Watershed Therapeutics raised?
Watershed Therapeutics has raised $300k across 1 round on record. The most recent is an undisclosed round of $300k announced in Apr 2026.
When did Watershed Therapeutics last raise funding?
Watershed Therapeutics' most recent funding round on record is an undisclosed round of $300k, announced in Apr 2026.
Who founded Watershed Therapeutics?
FundedIQ lists Topher Kinsella (Founder) at Watershed Therapeutics.
Where is Watershed Therapeutics headquartered?
Watershed Therapeutics is based in Los Altos, California, United States.
How many employees does Watershed Therapeutics have?
Watershed Therapeutics is in the 1-10 employee band.
How does Watershed Therapeutics' funding compare to other Biotechnology startups?
Watershed Therapeutics' latest round of $300k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Watershed Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Watershed Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.